Barclays
LFMD icon

Barclays’s LifeMD LFMD Stock Holding History

Barclays’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.8K Sell
6,238
-955
-13% -$4.21K ﹤0.01% 4532
2026
Q1 		$26K Sell
7,193
-53,835
-88% -$186K ﹤0.01% 4516
2025
Q4 		$208K Buy
61,028
+7,300
+14% +$35.4K ﹤0.01% 4286
2025
Q3 		$365K Sell
53,728
-9,755
-15% -$80.6K ﹤0.01% 3985
2025
Q2 		$865K Buy
63,483
+20,341
+47% +$192K ﹤0.01% 3437
2025
Q1 		$235K Sell
43,142
-13,631
-24% -$77.3K ﹤0.01% 3957
2024
Q4 		$281K Buy
56,773
+7,756
+16% +$40.7K ﹤0.01% 4146
2024
Q3 		$257K Buy
49,017
+37,112
+312% +$214K ﹤0.01% 4163
2024
Q2 		$81.7K Sell
11,905
-14,758
-55% -$135K ﹤0.01% 4006
2024
Q1 		$274K Sell
26,663
-22,710
-46% -$168K ﹤0.01% 3944
2023
Q4 		$409K Buy
49,373
+26,604
+117% +$191K ﹤0.01% 4005
2023
Q3 		$142K Buy
+22,769
New +$98.7K ﹤0.01% 3440

Other funds holding LFMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Barclays's LFMD Position: Q2 2026 in Review

Barclays reduced its LifeMD (LFMD) stake by 13% in Q2 2026, selling an estimated $4.21K and leaving 6,238 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4532.

Barclays first reported a position in LFMD in Q3 2023 and has held it in 12 quarters since. The position peaked at $865K in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Barclays held 6,238 shares of LifeMD worth $25.8K as of Q2 2026.
  • Barclays sold 955 LifeMD shares in Q2 2026, an estimated $4.21K.
  • LifeMD made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4532 holding.
  • Barclays first reported a position in LifeMD in Q3 2023 and has held it in 12 quarters since.
  • Barclays's LifeMD position peaked at $865K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.